This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vollstedt, S.
Right arrow Articles by Suter, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vollstedt, S.
Right arrow Articles by Suter, M.

 Previous Article  |  Next Article 

Journal of Virology, October 2001, p. 9596-9600, Vol. 75, No. 20
0022-538X/01/$04.00+0   DOI: 10.1128/JVI.75.20.9596-9600.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Interleukin-12- and Gamma Interferon-Dependent Innate Immunity Are Essential and Sufficient for Long-Term Survival of Passively Immunized Mice Infected with Herpes Simplex Virus Type 1

Sabine Vollstedt,1 Marco Franchini,1 Gottfried Alber,2 Mathias Ackermann,1 and Mark Suter1,*

Institute of Virology, University of Zurich, Zurich, Switzerland,1 and Institute of Immunology, Faculty of Veterinary Medicine, University of Leipzig, Leipzig, Germany2

Received 16 April 2001/Accepted 12 July 2001

Interferon (IFN) type I (alpha/beta IFN [IFN-alpha /beta ]) is very important in directly controlling herpes simplex virus type I (HSV-1) replication as well as in guiding and upregulating specific immunity against this virus. By contrast, the roles of IFN type II (IFN-gamma ) and antibodies in the defense against HSV-1 are not clear. Mice without a functional IFN system and no mature B and T cells (AGR mice) did not survive HSV-1 infection in the presence or absence of neutralizing antibodies to the virus. Mice without a functional IFN type I system and with no mature B and T cells (AR129 mice) were unable to control infection with as little as 10 PFU of HSV-1 strain F. By contrast, in the presence of passively administered neutralizing murine antibodies to HSV-1, some AR129 mice survived infection with up to104 PFU of HSV-1. This acute immune response was dependent on the presence of interleukin-12 (IL-12) p75. Interestingly, some virus-infected mice stayed healthy for several months, at which time antibody to HSV-1 was no longer detectable. Treatment of these virus-exposed mice with dexamethasone led to death in approximately 40% of the mice. HSV-1 was found in brains of mice that did not survive dexamethasone treatment, whereas HSV-1 was absent in those that survived the treatment. We conclude that in the presence of passively administered HSV-1-specific antibodies, the IL-12-induced IFN-gamma -dependent innate immune response is able to control low doses of virus infection. Surprisingly, in a significant proportion of these mice, HSV-1 appears to persist in the absence of antibodies and specific immunity.


* Corresponding author. Mailing address: Institute of Virology, University of Zurich, Winterthurerstr. 266a, CH-8057 Zurich, Switzerland. Phone: 41 1 635 87 17. Fax: 41 1 635 89 11. E-mail: msuter{at}vetvir.unizh.ch.


Journal of Virology, October 2001, p. 9596-9600, Vol. 75, No. 20
0022-538X/01/$04.00+0   DOI: 10.1128/JVI.75.20.9596-9600.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Liu, Y., Haas, D. L., Poore, S., Isakovic, S., Gahan, M., Mahalingam, S., Fu, Z. F., Tripp, R. A. (2009). Human Metapneumovirus Establishes Persistent Infection in the Lungs of Mice and Is Reactivated by Glucocorticoid Treatment. J. Virol. 83: 6837-6848 [Abstract] [Full Text]  
  • Sorensen, L. N., Reinert, L. S., Malmgaard, L., Bartholdy, C., Thomsen, A. R., Paludan, S. R. (2008). TLR2 and TLR9 Synergistically Control Herpes Simplex Virus Infection in the Brain. J. Immunol. 181: 8604-8612 [Abstract] [Full Text]  
  • Banerjee, K., Biswas, P. S., Rouse, B. T. (2005). Elucidating the protective and pathologic T cell species in the virus-induced corneal immunoinflammatory condition herpetic stromal keratitis. J. Leukoc. Biol. 77: 24-32 [Abstract] [Full Text]  
  • Banerjee, K., Biswas, P. S., Kumaraguru, U., Schoenberger, S. P., Rouse, B. T. (2004). Protective and Pathological Roles of Virus-Specific and Bystander CD8+ T Cells in Herpetic Stromal Keratitis. J. Immunol. 173: 7575-7583 [Abstract] [Full Text]  
  • Pollara, G., Jones, M., Handley, M. E., Rajpopat, M., Kwan, A., Coffin, R. S., Foster, G., Chain, B., Katz, D. R. (2004). Herpes Simplex Virus Type-1-Induced Activation of Myeloid Dendritic Cells: The Roles of Virus Cell Interaction and Paracrine Type I IFN Secretion. J. Immunol. 173: 4108-4119 [Abstract] [Full Text]  
  • Vollstedt, S., Arnold, S., Schwerdel, C., Franchini, M., Alber, G., Di Santo, J. P., Ackermann, M., Suter, M. (2004). Interplay between Alpha/Beta and Gamma Interferons with B, T, and Natural Killer Cells in the Defense against Herpes Simplex Virus Type 1. J. Virol. 78: 3846-3850 [Abstract] [Full Text]  
  • Friedl, G., Hofer, M., Auber, B., Sauder, C., Hausmann, J., Staeheli, P., Pagenstecher, A. (2004). Borna Disease Virus Multiplication in Mouse Organotypic Slice Cultures Is Site-Specifically Inhibited by Gamma Interferon but Not by Interleukin-12. J. Virol. 78: 1212-1218 [Abstract] [Full Text]  
  • Hooks, J. J., Wang, Y., Detrick, B. (2003). The Critical Role of IFN-{gamma} in Experimental Coronavirus Retinopathy. IOVS 44: 3402-3408 [Abstract] [Full Text]  
  • Glass, W. G., Lane, T. E. (2002). Functional Expression of Chemokine Receptor CCR5 on CD4+ T Cells during Virus-Induced Central Nervous System Disease. J. Virol. 77: 191-198 [Abstract] [Full Text]  
  • Freude, S., Hausmann, J., Hofer, M., Pham-Mitchell, N., Campbell, I. L., Staeheli, P., Pagenstecher, A. (2002). Borna Disease Virus Accelerates Inflammation and Disease Associated with Transgenic Expression of Interleukin-12 in the Central Nervous System. J. Virol. 76: 12223-12232 [Abstract] [Full Text]  
  • Pyles, R. B., Higgins, D., Chalk, C., Zalar, A., Eiden, J., Brown, C., Van Nest, G., Stanberry, L. R. (2002). Use of Immunostimulatory Sequence-Containing Oligonucleotides as Topical Therapy for Genital Herpes Simplex Virus Type 2 Infection. J. Virol. 76: 11387-11396 [Abstract] [Full Text]  
  • Carr, D. J. J., Noisakran, S. (2002). The Antiviral Efficacy of the Murine Alpha-1 Interferon Transgene against Ocular Herpes Simplex Virus Type 1 Requires the Presence of CD4+, {alpha}/{beta} T-Cell Receptor-Positive T Lymphocytes with the Capacity To Produce Gamma Interferon. J. Virol. 76: 9398-9406 [Abstract] [Full Text]  
  • Brockman, M. A., Knipe, D. M. (2002). Herpes Simplex Virus Vectors Elicit Durable Immune Responses in the Presence of Preexisting Host Immunity. J. Virol. 76: 3678-3687 [Abstract] [Full Text]